1/Thrilled to share our most recent efforts Nature Medicine on joint multi-omic analyses unravelling the comprehensive immune landscapes in myocardial infarction and chronic coronary syndromes
nature.com/articles/s4159…

#LuxValve shows interesting results in the beautiful talk of Prof jörg hausleiter ! 👏🏼

This is also one of the few #devices for #anulus diam >55 mm, so it is very important to see that the results between the device #sizes are similar!

#EuroPCR #PCRTricuspid #TR PCRonline 🫀

💥Feel free to read our new article on #mitralregurgitation proportionality in atrial functional MR published in ESC Heart Failure.
🔗 pubmed.ncbi.nlm.nih.gov/38602287/

Lukas Stolz Daniel Kalbacher Univ.-Prof. Dr. Ralph Stephan von Bardeleben ChristosIliadis Paul Grayburn

In atrial functional mitral regurgitation, the natural history suggests risk of the development of #HFpEF . See the details here: bit.ly/3xGsEQd

#JACC Mack Eleid Jwan A. Naser Francisco Alexandrino

Nice Review of SMR Phenotypes bit.ly/MVPheno_TEER and OMT for SMR: bit.ly/OMT_FMR Paul Grayburn Anna Sannino MD PhD FASE jörg hausleiter Ulrich Jorde JACC Journals Circulation

Original Article: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis (DEDICATE-DZHK6) nej.md/3TLx8MT

Editorial: Another Early Win for TAVI in Low-Risk Patients nej.md/3J5F7j5

American College of Cardiology #ACC24

Don’t miss it!

⚡️ #TTEER for TR and right #heartfailure ⚡️

TRILUMINATE RCT: Symptom⬇️, but translating to real-world practice?

Lukas Stolz , jörg hausleiter et al.* unveil insights in JACC Journals

Check 🔑points in commentary w/ Jonathan Curio PCRonline 🫀: rb.gy/oyxqga

I'm honored and very happy to be awarded this year's Young Investigator Award in Thrombosis and Vascular Biology by the German Society for Thrombosis and Hemostasis (gth-online.org/preise/) for our study on mechanisms of platelet migration in Blood Journal! Young-DZHK

Moderate/severe TR raises #HeartFailure & #CVdeath risk in #HFrEF patients, highlighting the need for TR management. This study also shows that omecamtiv mecarbil’s effectiveness remains unaffected by TR severity. bit.ly/4cc8kGk

#JACCHF Marianna Adamo Marco Metra

At #PCRLV , Lukas Stolz, Francesco Saia, Neil Fam and more shared thoughts on the new TRILUMINATE trial analysis presented at the conference. Findings show that real world patients undergoing T-TEER may not resemble the patients in the trial. tctmd.com/news/ideal-tri…

#PCRTricuspid

Happy to share our latest research on different phenotypes of Tricuspid Regurgitation Sara Bombace Federico Fortuni Paul Grayburn Philipp Lurz Maria chiara meucci Victoria Delgado RTHahnMD Denisa Muraru Nina Ajmone Marsan Julia Grapsa Dee Dee Wang MD
sciencedirect.com/science/articl…

In this large cohort of 962 pts who underwent T-TEER, #TRILUMINATE -eligible pts had comparable TR reduction, NYHA class & #6MWT at follow-up vs TRILUMINATE-ineligible. However, 1-yr mortality was significantly ⬇️ in TRILUMINATE-eligible pts bit.ly/3SO87A0

#JACCINT #TEER

Observed differences in #survival & #HHF outcomes suggest a limited generalizability of #TRILUMINATE to real-world conditions 👉 bit.ly/49rQs8u #tricuspid #TEER #HF Lukas Stolz Mamas A. Mamas John Mandrola, MD Sanjay Kaul MIЯVΛƬ #IC Professor Vijay Kunadian Julia Grapsa Tuğba Kemaloğlu Öz, A/Prof JACC Journals

At #PCRLV , Lukas Stolz presented data that used the EuroSMR to determine risk scores for patients undergoing the procedure for secondary mitral regurgitation. More on the new AI-based algorithm and comments from Davide Capodanno, Yohei Turi Ohno and Ignacio J. Amat: tctmd.com/news/eurosmr-s…

Happy to share our viewpoint article „ #TMVR at an inflection point: lessons learned and the path forward“ just published in European Society of Cardiology Journals Juan F. Granada academic.oup.com/eurheartj/arti…

Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study just published in #EHJ
European Society of Cardiology European Society of Cardiology Journals #CardioTwitter

academic.oup.com/eurheartj/adva…

Finally published. Have a look at the new EuroSMR risk score!

Great EuroSMR Team effort!

T-TEER Therapie.
💥Unser Artikel beschreibt den wissenschaftlichen und technischen Fortschritt, sowie vieles, was für die Patientenselektion und das Outcome relevant ist.
Dankbar, dass unser Artikel als Cover-Bild ausgewählt wurde.jörg hausleiter Ludwig T Weckbach Lukas Stolz @Cardio_LMU